CLINICAL_TRIALS
research
· 2026-04-17
Clinical Trial Update: Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Gemcitabine Plus Paclitaxel [Phase 2]
Summary
A Phase 2 trial is evaluating auricular point stimulation plus dexamethasone to prevent chemotherapy-induced nausea and vomiting from gemcitabine plus paclitaxe…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Nausea and Vomiting Caused by Chemotherapy | Phase 2 | Status: RECRUITING